ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,562Medicare Part D Prescriptions Filled, Including Refills

Rank: 256 out of 2035

$648K Total Retail Price of All Prescriptions

Rank: 166 out of 2035

419 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 5,115 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 565 258 S3 1 2
SIMVASTATIN 387 279 2 1
OMEPRAZOLE 316 236 3 5
LISINOPRIL 284 171 4 3
LEVOTHYROXINE SODIUM 269 174 5 4
ZOLPIDEM TARTRATE 173 92 6 21
ATORVASTATIN CALCIUM 139 97 7 13
FLUTICASONE PROPIONATE 129 75 8 29
CITALOPRAM HBR 128 70 9 20
CYCLOBENZAPRINE HCL 127 25 R 10 64
AMLODIPINE BESYLATE 124 102 11 6
METFORMIN HCL 123 71 12 9
METOPROLOL TARTRATE 114 91 13 8
TRAMADOL HCL 114 60 13 19
FUROSEMIDE 107 97 15 7
GABAPENTIN 107 68 15 14
LOSARTAN POTASSIUM 103 86 17 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 80 18 26
ATENOLOL 96 75 19 10
MORPHINE SULFATE ER 96 24 S2 19 86
TAMSULOSIN HCL 94 87 21 25
PROAIR HFA 94 41 21 31
ADVAIR DISKUS 91 46 23 38
PRAVASTATIN SODIUM 91 72 23 17
METOPROLOL SUCCINATE 85 62 25 16
FENOFIBRATE 85 48 25 82
LOSARTAN-HYDROCHLOROTHIAZIDE 76 71 27 47
LYRICA 75 0 28 89
CARVEDILOL 74 56 29 22
TRAZODONE HCL 73 27 30 50
SPIRIVA 71 44 31 44
ALLOPURINOL 68 54 32 34
LOVASTATIN 68 68 32 33
NEXIUM 67 45 34 51
POTASSIUM CHLORIDE 66 48 35 18
METFORMIN HCL ER 62 60 36 78
MELOXICAM 62 39 36 56
WARFARIN SODIUM 60 47 38 11
HYDROCHLOROTHIAZIDE 60 44 38 12
CRESTOR 60 34 38 41
PAROXETINE HCL 60 27 38 69
CLOPIDOGREL 56 33 42 30
FENTANYL 55 0 S2 43 53
GLIPIZIDE 55 41 43 54
LANTUS SOLOSTAR 53 26 45 66
IBUPROFEN 52 27 46 43
OXYCODONE-ACETAMINOPHEN 50 19 S2 47 181
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.